Thrombospondins and tumor angiogenesis
- 1 September 2001
- journal article
- review article
- Published by Elsevier in Trends in Molecular Medicine
- Vol. 7 (9) , 401-407
- https://doi.org/10.1016/s1471-4914(01)02102-5
Abstract
No abstract availableKeywords
This publication has 60 references indexed in Scilit:
- Expression of the Angiogenesis Markers Vascular Endothelial Growth Factor-A, Thrombospondin-1, and Platelet-Derived Endothelial Cell Growth Factor in Human Sporadic Adrenocortical Tumors: Correlation with Genotypic AlterationsJournal of Clinical Endocrinology & Metabolism, 2000
- Activation of Platelet-transforming Growth Factor β-1 in the Absence of Thrombospondin-1Published by Elsevier ,2000
- Thrombospondin-1 expression and clinical implications in malignant pleural mesotheliomaCancer, 1999
- Bovine Thrombospondin-2: Complete Complementary Deoxyribonucleic Acid Sequence and Immunolocalization in the External Zones of the Adrenal CortexEndocrinology, 1999
- Viral Myc Oncoproteins in Infected Fibroblasts Down-modulate Thrombospondin-1, a Possible Tumor Suppressor GeneJournal of Biological Chemistry, 1996
- Repression of thrombospondin-1 expression, a natural inhibitor of angiogenesis, in polyoma middle T transformed NIH3T3 cellsCancer Letters, 1996
- Inhibition of breast cancer progression by an antibody to a thrombospondin-1 receptorSurgery, 1996
- Inhibition of Angiogenesis by Thrombospondin-2Biochemical and Biophysical Research Communications, 1995
- Colocalization of thrombospondin and syndecan during murine developmentDevelopmental Dynamics, 1992
- Thrombospondin in malignant and non-malignant breast tissueEuropean Journal of Cancer and Clinical Oncology, 1989